Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Historical Control Study to Evaluate the Effects of Personalized Patient Counselling on Persistence to Enbrel® Therapy in Subjects With Rheumatoid Arthritis (PerSuit)

NCT02346877 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02346877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02346877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Historical Control Study to Evaluate the Effects of Personalized Patient Counselling on Persistence to Enbrel® Therapy in Subjects With Rheumatoid Arthritis (PerSuit)
Lead sponsor
Amgen
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2015
Completion date
October 31, 2015
Enrollment
19 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

persistence to enbrel